CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
399-96-2 | 4-氨基-2-氟苯酚; 3-氟-4-羥基苯胺 | 4-Amino-2-fluorophenol; 2-Fluoro-4-aminophenol | ![]() | C6H6FNO | 詳情 | 供應(yīng)商 |
69123-90-6 | 非西他濱; 4-氨基-1-[(2R,3S,4R,5R)-3-氟-4-羥基-5-(羥甲基)氧雜環(huán)戊-2-基]-5-碘嘧啶-2-酮 | Fiacitabine; 4-Amino-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one | ![]() | C9H11FIN3O4 | 詳情 | 供應(yīng)商 |
83558-87-6 | 2,2-雙(3-氨基-4-羥基苯基)六氟丙烷 | 2,2-Bis(3-amino-4-hydroxyphenyl)hexafluoropropane; 1,1-Bis(3-amino-4-hydroxyphenyl)-2,2,2-trifluoro-1-(trifluoromethyl)ethane; 2,2-Bis(3-amino-4-hydroxyphenyl)hexafluoropropane; 4,4'-(Hexafluoroisopropylidene)bis[2-aminophenol]; Bis(aminophenol) AF; Di(aminobisphenol) AF; Hexafluoro-2,2-bis(3-amino-4-hydroxyphenyl)propane; 2,2-Bis(3-amino-4-hydrophenyl) hexafluoropropane; | ![]() | C15H12F6N2O2 | 詳情 | 供應(yīng)商 |
87771-40-2 | 碘氟醇; 碘佛醇; N,N'-雙(2,3-二羥基丙基)-5-[(2-羥基乙;)-(2-羥乙基)氨基]-2,4,6-三碘苯-1,3-二甲酰胺 | Ioversol; N,N'-Bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide | ![]() | C18H24I3N3O9 | 詳情 | 供應(yīng)商 |
90509-02-7 | 魯苯達唑; 5-羥基-2-苯并咪唑氨基甲酸甲酯對氟苯磺酰酯 | Luxabendazole; Methyl 5-hydroxy-2-benzimidazolecarbamate p-fluorobenzenesulfonate | ![]() | C15H12FN3O5S | 詳情 | 供應(yīng)商 |
95058-81-4 | 吉西他濱; 4-氨基-1-[3,3-二氟-4-羥基-5-(羥甲基)氧雜環(huán)戊-2-基]嘧啶-2-酮 | Gemcitabine; 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one | ![]() | C9H11F2N3O4 | 詳情 | 供應(yīng)商 |
110862-48-1 | 阿伐他汀; 阿托伐他汀; (3S,5S)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲;)-5-異丙基吡咯-1-基]-3,5-二羥基? | Atorvastatin; (3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid | ![]() | C33H35FN2O5 | 詳情 | 供應(yīng)商 |
122111-03-9 | 鹽酸吉西他濱; 吉西他賓鹽酸鹽; 4-氨基-1-(3,3-二氟-4-羥基-5-羥甲基四氫呋喃-2-基)-1H-嘧啶-2-酮鹽酸鹽 | Gemcitabine hydrochloride; 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-pyrimidin-2-one hydrochloride | ![]() | C9H12ClF2N3O4 | 詳情 | 供應(yīng)商 |
125995-03-1 | 阿托伐他汀內(nèi)酯; (4R,6R)-6-{2-[2-(4-氟苯基)-5-異丙基-3-苯基-4-(苯基氨基甲酰基)吡咯-1-基]乙基}-4-羥基四 | Atorvastatin lactone; (4R,6R)-6-{2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one | ![]() | C33H33FN2O4 | 詳情 | 供應(yīng)商 |
128173-53-5 | D-DTTA鹽; (-)-4-[4-二甲氨基-1-(4-氟苯基)-1-羥基丁基]-3-羥甲基苯腈D-(+)-二對甲苯甲酰酒石酸鹽(2:1) | (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-; (S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate (2:1) | ![]() | C60H64F2N4O12 | 詳情 | 供應(yīng)商 |
130579-75-8 | 依利色林; (Z,E)-1-(2-氟苯基)-3-(4-羥基苯基)-2-丙烯-1-酮O-[2-(二甲基氨基)乙基]肟 | Eplivanserin; (Z,E)-1-(2-Fluorophenyl)-3-(4-hydroxyphenyl)-2-propen-1-one O-[2-(dimethylamino)ethyl]oxime | ![]() | C19H21FN2O2 | 詳情 | 供應(yīng)商 |
134523-00-5 | 阿伐他汀; 阿托伐他汀; (3R,5R)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲;)-5-異丙基-吡咯-1-基]-3,5-二羥基 | Atorvastatin; (3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid | ![]() | C33H35FN2O5 | 詳情 | 供應(yīng)商 |
287714-41-4 | 羅伐他汀; 羅素他汀; 羅蘇伐他汀; 7-[4-(4-氟苯基)-6-異丙基-2-(甲基-甲磺酰-氨基)-嘧啶-5-基]-3,5-二羥基庚-6 | Rosuvastatin; 7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid | ![]() | C22H28FN3O6S | 詳情 | 供應(yīng)商 |
355806-00-7 | 瑞舒伐他汀叔丁酯; (6E)-7-[4-(4-氟苯基)-6-異丙基-2-[甲基(甲磺酰)氨基]嘧啶-5-基]-(3R,5S)-3,5-二羥基庚-6 | tert-Butyl rosuvastatin; tert-Butyl (6E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoate; (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[(methanesulfonyl)me | ![]() | C26H36FN3O6S | 詳情 | 供應(yīng)商 |
518048-05-0 | 雷特格韋; N-(2-(4-(4-氟芐基氨基甲;)-5-羥基-1-甲基-6-氧代-1,6-二氫嘧啶-2-基)丙-2-基)-5-甲基-1,3,4-? | Raltegravir; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide; N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide; Raltegravir | ![]() | C20H21FN6O5 | 詳情 | 供應(yīng)商 |
744254-10-2 | 21-氨基-9-氟-11,17-二羥基-16-甲基孕甾-1,4-二烯-3,20-二酮鹽酸鹽 | 21-Amino-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione hydrochloride; 21-Amino-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione hydrochloride | ![]() | C22H31ClFNO4 | 詳情 | 供應(yīng)商 |
871038-72-1 | 雷特格韋鉀鹽; N-(2-(4-(4-氟芐基氨基甲;)-5-羥基-1-甲基-6-氧代-1,6-二氫嘧啶-2-基)丙-2-基)-5-甲基-1,3 | Raltegravir potassium; N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide potassium salt; MK 0518 | ![]() | C20H20FKN6O5 | 詳情 | 供應(yīng)商 |
915769-50-5 | 多韋替尼; 4-氨基-5-氟-3-[6-(4-甲基-1-哌嗪基)-1H-苯并咪唑-2-基]-2(1H)-喹啉酮2-羥基丙酸鹽一水物 | Dovitinib; 4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone 2-hydroxypropanoate hydrate (1:1:1) | ![]() | C21H21FN6O.C3H6O3.H2O | 詳情 | 供應(yīng)商 |
68912-12-9 | [2-[[[[3-[[4-氟-6-[(3-磺基苯基)氨基]-1,3,5-三嗪-2-基]氨基]-2-羥基-5-磺苯基]偶氮]-苯基甲基]偶氮]-4-磺 | Cuprate, [2-[[[[3-[[4-fluoro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulfophe; Cuprate(4-),[2-[[[[3-[[4-fluoro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-(hydroxy-kO)-5-sulfophenyl]azo-kN2]phenylmethyl]azo-kN1]-4-sulfobenzoato(6-)-kO]-, tetrasodium (9CI); Cuprate(4-), [2-[[[[3-[[4-fluoro-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulfophenyl]azo]phenylmethyl]azo]-4-sulfobenzoato(6-)]-,tetrasodium; Benzoic acid,2-[[[[3-[[4-fluoro-6-[(3-sulfophenyl)azo]-1,3,5-triazin-2-yl]amino]-2-hydroxy-5-sulfophenyl]azo]phenylmethyl]azo]-4-sulfo-,copper complex | ![]() | C29H16CuFN9O12S3.4Na | 詳情 | 供應(yīng)商 |
81611-05-4 | [2-[[α-[[3-[(5-氯-2,6-二氟-4-嘧啶基)氨基]-2-羥基-5-磺酸苯基]偶氮]芐基]偶氮]-5-磺酸基苯甲酸]合? | Trisodium [2- [[.alpha.-[[3-[(5-chloro-2,6-difluoro-4-pyrimidinyl) amino]-2-hydroxy-5-sulphophenyl] | 無 | 詳情 | 供應(yīng)商 |